Retrieved September 12, 2009
In a randomized, double-blind, single-center trial, G-CSF significantly improved 90-day survival and reduced model for end-stage liver disease (MELD) and Maddreys discriminant scores in patients with steroid-nonresponsive severe AH
Waziri R, Wilcox J, Sherman AD, Mott J
Citrullination in extra-articular manifestations of rheumatoid arthritis
The Peptide Reclassification: What It Means for Dermatology The biggest regulatory shift affecting dermatology compounding in 2026 isnt about topical steroids or retinoidsits about peptides
* [Highly Potent Ingredients] Packed with 5% of Glutathione, along with Tranexamic Acid and Niacinamide, this serum is designed to give your skin that radiant glow